The largest database of trusted experimental protocols
> Procedures > Therapeutic or Preventive Procedure > Transcranial Magnetic Stimulation, Repetitive

Transcranial Magnetic Stimulation, Repetitive

Transcranial Magnetic Stimulation, Repetitive (rTMS) is a non-invasive brain stimulation technique that uses magnetic fields to induce electrical currents in the brain.
This technique has been used for the treatmenet of various neurological and psychiatric disorders, as well as for research purposes. rTMS involves the repetitive application of magnetic pulses to a specific area of the brain, which can modulate cortical excitability and activity.
The optimal protocols for rTMS, including stimulation parameters and target brain regions, are ares of active research and development.
PubCompare.ai's AI-driven platform can help researchers and clinicians identify the best reproducible and accurate rTMS methods by locating and comparing protocols from literature, pre-prints, and patents.

Most cited protocols related to «Transcranial Magnetic Stimulation, Repetitive»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Brain Cerebrovascular Accident Congenital Abnormality Cortex, Cerebral Electroconvulsive Therapy Motor Cortex Multiple Sclerosis Muscle Rigidity Neoplasms Neuronavigation Patients Safety Scalp Seizures Therapeutics Tissues Transcranial Magnetic Stimulation, Repetitive

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017
Connectome Depressive Disorder, Treatment-Resistant Dorsolateral Prefrontal Cortex Electricity Fingers Healthy Volunteers Major Depressive Disorder Memory, Short-Term Motor Cortex Neuronavigation Patients Perfusion Pharmaceutical Preparations Scalp Transcranial Magnetic Stimulation, Repetitive Vision

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2015
Cortex, Cerebral Dorsolateral Prefrontal Cortex Neuronavigation Scalp Transcranial Magnetic Stimulation, Repetitive
The reviewed study sample (n = 51 experiments in ~650 participants with the majority being healthy volunteers) represents approximately 40% of all TMS-EEG studies identified during the reviewed period.
The reminder of the TMS-EEG studies (other 60%) consisted of single-pulse TMS experiments studying the TMS-evoked electrical activity and its spreading immediately after stimulation (<1 s) in the absence of pulse-effect summation, or of rTMS experiments that inspected background EEG for TMS-induced epileptiform activity for safety evaluation (for a detailed review of this aspect see Rossi et al. 2009 ).
All reviewed studies either used TMS protocols with repeated pulse administration at fixed pulse repetition frequencies (conventional rTMS protocols) or the protocols of TBS (Huang et al. 2005 (link)) or PAS (Classen et al. 2004 (link)). Within the conventional protocols, only a discrete number of frequencies were tested (0.9–1 Hz: n = 17, 5 Hz: n = 6, 10 Hz: n = 8, 20 Hz: n = 4, 25 Hz: n = 1) often in association with varying number of trains, train-duration, intertrain interval, and TMS-intensities across studies, leading to a large number of employed parameter-combinations (see tables). Three studies used very low frequencies of 0.6 Hz (Van Der Werf and Paus 2006 (link)) and 0.2 Hz (Urushihara et al. 2006 (link); Hosono et al. 2008 (link)) and are discussed separately where of interest. To reduce this parameters space, we collapse for our analysis across low-frequency (0.9–1 Hz) versus high-frequency (5 Hz and above) protocols. This grouping seems reasonable also because previous studies on motor cortex excitability have reported these two protocols to differ in terms of aftereffect-direction (suppression vs. facilitation) (e.g. reviewed in Hallett 2007 (link)). Note that no TMS-EEG study has looked at aftereffects of conventional TMS in the frequency-range between 1 and 5 Hz, where the reversal of effect-direction is to be expected. In regards to TBS and PAS, employed parameters were more uniform across studies.
Table 1 provides a summary of TMS parameters broken down by TMS-protocols (average and range over studies/experiments). The figures and Table 2 depict the results per individual study/experiment.
Publication 2009
Electricity Healthy Volunteers Lanugo Motor Cortex Pulse Rate Safety Shock Transcranial Magnetic Stimulation, Repetitive Treatment Protocols

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Dietary Supplements Dorsolateral Prefrontal Cortex POU3F2 protein, human Smoke Transcranial Magnetic Stimulation, Repetitive

Most recents protocols related to «Transcranial Magnetic Stimulation, Repetitive»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Ethics Committees, Research Homo sapiens Patients Psychiatrist Transcranial Magnetic Stimulation, Repetitive
Participants underwent real-rTMS [100% resting motor threshold (rMT)] and sham-rTMS (30% rMT) of pre-SMA in two separate sessions at least 1 week apart. The session order was counterbalanced across participants. For both sessions, over the course of 30 min 1800 biphasic pulses were applied over pre-SMA with a frequency of 1 Hz using a robot arm-controlled figure-eight coil (Ø, 2 × 75 mm; model MCF-B65, Medtronic). The coil was positioned in a lateral-to-medial orientation such that the strongest intracranial current went in a left-to-right direction, thus preferentially targeting the right hemisphere.
The individual resting motor threshold was determined in all sessions using the freeware TMS Motor Threshold Assessment Tool version 2.0 (MTAT 2.0; http://www.clinicalresearcher.org/software.htm), where the threshold is estimated using a maximum-likelihood strategy (“threshold hunting”). The rMT was assessed in the right hemisphere, and the motor evoked potential (MEP) of the left first dorsal interosseous was used as readout using the same coil type as the one used during the experiment. MEPs had to exceed 50 µV to be considered present. At the end of the stimulation, we asked participants to rate (on a scale of 1–10) “How effective do you feel the stimulation was?” (without explaining in further detail what was meant by “effective”) and “How uncomfortable did you find the stimulation?”
Full text: Click here
Publication 2023
3-O-(methylthiomethyl)apiitol tetraacetate CTSL protein, human Evoked Potentials, Motor Feelings Pulses Transcranial Magnetic Stimulation, Repetitive
Statistical analyses of behavior were performed in R (R Foundation for Statistical Computing). We used a linear mixed model implemented in the nlme package (see https://CRAN.R-project.org/package=nlme) with regressors motor context (act to continue, act to stop), rTMS condition (real-rTMS, sham-rTMS), and session number (session 1, session 2) for the analysis of mean stopping amounts.
Response times (RTs) were log-transformed to meet the assumption of normal distribution. The mean ± SD is reported. For correlational analyses, Pearson’s r is reported. To test whether participants might have been aware of differences between real and sham stimulation, we used Bayesian paired t tests to test for differences between their ratings of stimulation effectiveness and discomfort (JASP software version 0.14.3). We used Bayesian tests to be able to test for the absence of an effect. Bayes factors are classified according to the scheme of Jeffreys [1998 ; Bayes Factor (BF) = 1–3, anecdotal evidence; BF = 3–10, moderate evidence; BF = 10–30, strong evidence; BF = 30–100, very strong evidence; BF > 100, extreme evidence]. BF10 denotes evidence in favor of a given model against the null model, while BF01 denotes evidence in favor of the null model (Keysers et al., 2020 (link)).
Full text: Click here
Publication 2023
Fibrinogen Transcranial Magnetic Stimulation, Repetitive
Scans were acquired using a 3 T scanner (Verio, Siemens) with a 32-channel head coil. To relate the blood oxygenation level-dependent (BOLD) signal acquired with fMRI to anatomic brain structures and for rTMS neuronavigation a structural T1-weighted image was acquired [MPRAGE; repetition time (TR), 1900 ms; echo time (TE), 2.32 ms; flip angle, 9°; in-plane resolution, 0.89 × 0.89 mm; slice thickness, 0.9 mm; field of view (FOV), 256 mm). To assess task-related neural activity, regional BOLD signal changes were measured using a T2*-weighted EPI sequence (TR, 1650 ms; TE, 26 ms; flip angle, 74°). A total of 1459 volumes with 32 slices in ascending order were acquired per session (in-plane resolution, 3 × 3 mm; FOV, 192 mm). Axial slices were arranged parallel to the bicommissural line. Respiration and pulse were obtained with a pneumatic thoracic belt and pulse oximeter, respectively.
Full text: Click here
Publication 2023
BLOOD Brain Cell Respiration ECHO protocol fMRI Head Nervousness Neuronavigation Pulse Rate Radionuclide Imaging Transcranial Magnetic Stimulation, Repetitive
We retrieved all observational studies and clinical trials related to patients with mood disorders or to their caregivers. In the case of clinical trials, we included all interventions, such as drugs, lifestyle modification, psycho-educational treatments, and behavioral treatments. We extracted data for studies registered in the CTRI database between June 15, 2009 and December 31, 2019. We used the three advanced search options at the CTRI website: ‘scientific title of the study,’ ‘health condition/problem studied,’ and ‘intervention and comparator agent’ to identify relevant observational studies and interventional clinical trials.
For the first two options, we searched the database using disorder keywords such as “depression”, “depressive disorder”, “major depressive disorder”, “treatment-resistant depression”, “mania”, “bipolar disorder”, and “bipolar depression”, entered individually. For the third option, we searched using names of psychotropic drugs and other treatments, such as “olanzapine”, “risperidone”, “cognitive behaviour therapy”, “electroconvulsive therapy”, repetitive transcranial magnetic stimulation, and deep brain stimulation, again entered individually. Two authors (NV, RJ) independently searched the CTRI database using these strategies, after which a final list of studies satisfying the eligibility criteria was made by removing duplicates. We excluded studies involving interventions related to Ayurveda, Unani, and other alternative systems of medicine because the results of such studies tend to be published in journals and other destinations that might not have been accessible to us in our literature search. We also excluded studies that were not conducted primarily in patients with the disorders listed above.
Publication 2023
Behavior Therapy Bipolar Disorder Cognitive Therapy Deep Brain Stimulation Depression, Bipolar Depressive Disorder, Treatment-Resistant Disorder, Depressive Electroconvulsive Therapy Eligibility Determination Major Depressive Disorder Mania Mood Disorders Olanzapine Patients Pharmaceutical Preparations Psychotropic Drugs Risperidone Transcranial Magnetic Stimulation, Repetitive

Top products related to «Transcranial Magnetic Stimulation, Repetitive»

Sourced in United Kingdom
The Magstim Rapid2 is a transcranial magnetic stimulation (TMS) device designed for use in research and clinical settings. It generates a rapidly changing magnetic field to induce electrical currents in the brain, allowing for non-invasive stimulation of specific brain regions. The Rapid2 offers adjustable stimulation parameters and can be used to investigate brain function and neural activity.
Sourced in United Kingdom
The Magstim Rapid2 stimulator is a medical device designed for the non-invasive stimulation of the brain. It generates brief magnetic pulses that can induce electrical currents in the targeted brain regions. The Rapid2 is a versatile tool that can be used in various research and clinical applications, but its detailed intended use should be determined by qualified professionals.
Sourced in Denmark
The MagPro R30 is a transcranial magnetic stimulation (TMS) device designed for research and clinical applications. It is a powerful, flexible, and user-friendly system that delivers precise magnetic stimulation to the brain. The MagPro R30 is capable of generating strong magnetic fields and can be used with a variety of coils to stimulate specific brain regions. The device is designed to meet the high standards of clinical and research environments.
Sourced in Denmark
The MagPro X100 is a transcranial magnetic stimulation (TMS) system designed for research and clinical applications. It is capable of generating magnetic pulses to stimulate the brain. The device features adjustable parameters to control the intensity, duration, and frequency of the magnetic pulses.
Sourced in United Kingdom
The Magstim Super Rapid stimulator is a non-invasive brain stimulation device. It generates magnetic pulses to stimulate specific areas of the brain. The device is designed to be used in research and clinical settings.
Sourced in United Kingdom
The Magstim Rapid stimulator is a medical device designed for transcranial magnetic stimulation (TMS) applications. It generates short, high-intensity magnetic pulses to stimulate specific areas of the brain. The core function of the Magstim Rapid stimulator is to provide a safe and controlled method of applying TMS for research and clinical purposes.
Sourced in Netherlands, Germany, United States
The Philips Achieva 3T is a magnetic resonance imaging (MRI) system that operates at a magnetic field strength of 3 Tesla. It is designed to provide high-quality imaging for a variety of clinical applications.
Sourced in Denmark
The MagPro X100 is a stimulator device designed for transcranial magnetic stimulation (TMS) applications. It generates precisely controlled magnetic pulses to stimulate neural activity in the brain. The device is capable of delivering a range of pulse shapes and intensities to support various TMS protocols.
Sourced in United States, United Kingdom, Germany, Canada, Japan, Sweden, Austria, Morocco, Switzerland, Australia, Belgium, Italy, Netherlands, China, France, Denmark, Norway, Hungary, Malaysia, Israel, Finland, Spain
MATLAB is a high-performance programming language and numerical computing environment used for scientific and engineering calculations, data analysis, and visualization. It provides a comprehensive set of tools for solving complex mathematical and computational problems.
Sourced in Denmark
The Cool-B65 A/P coil is a lab equipment product designed for magnetic stimulation. It features a figure-of-eight coil configuration with a 65 mm diameter. The coil is actively cooled to maintain consistent performance during operation.

More about "Transcranial Magnetic Stimulation, Repetitive"

Transcranial Magnetic Stimulation, Repetitive (rTMS) is a non-invasive brain stimulation technique that utilizes magnetic fields to induce electrical currents in the brain.
This method has been employed for the treatment of various neurological and psychiatric disorders, as well as for research purposes. rTMS involves the repetitive application of magnetic pulses to a specific area of the brain, which can modulate cortical excitability and activity.
The optimal protocols for rTMS, including stimulation parameters and target brain regions, are areas of active research and development.
Researchers and clinicians can leverage PubCompare.ai's AI-driven platform to identify the best reproducible and accurate rTMS methods by locating and comparing protocols from literature, pre-prints, and patents.
Advancements in rTMS technology have produced stimulators like the Magstim Rapid2, MagPro R30, MagPro X100, Magstim Super Rapid, and Magstim Rapid, which offer improved capabilities and precision.
Additionally, neuroimaging techniques such as Achieva 3T MRI can be used in conjunction with rTMS to enhance targeting and monitoring of brain activity.
Researchers also utilize software like MATLAB to design and analyze rTMS protocols, while coils like the Cool-B65 A/P coil provide specialized stimulation capabilities.
By leveraging these tools and resources, scientists can optimzie their rTMS research and product development, leading to more effective and reproducible therapeutic interventions.